Finance

Lists
Q3 2026 earnings • released • EPS beat +15.39% • Revenue beat +5.58%
See results
SBRA:NASDAQ
Sabra Health Care REIT Inc
$19.72
-0.10%
(-0.020) 1D
$19.72
0.00% (0.00)
After hours
Closed: Nov 2, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SBRA...
Open
$19.93
High
$19.93
Low
$19.63
Mkt. cap
5.04B
Avg. vol.
2.33M
Volume
3.40M
Dividend
6.09%
Quarterly dividend
$0.30
Ex-dividend date
Aug 14, 2026
P/E ratio
75.88
52-wk high
$22.77
52-wk low
$17.54
EPS
$0.26
Beta
0.65
Shares outstanding
255.46M
No. of employees
58
Open
$19.93
High
$19.93
Low
$19.63
Mkt. cap
5.04B
Avg. vol.
2.33M
Volume
3.40M
Dividend
6.09%
Quarterly dividend
$0.30
Ex-dividend date
Aug 14, 2026
P/E ratio
75.88
52-wk high
$22.77
52-wk low
$17.54
EPS
$0.26
Beta
0.65
Shares outstanding
255.46M
No. of employees
58
News stories
From web sources and news partners
About Sabra Health Care REIT Inc
CEO-
Employees58
Founded2010
HeadquartersTustin, California, United States
SectorReal estate investment trust
Websitesabrahealth.com
Analyst ratings
Based on 9 analysts giving stock ratings to SBRA in the past 3 months
Buy
Buy
4
Hold
5
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for SBRA in the last 3 months.
Highest
Current $19.72
$24.00 (+21.70%)
Average
$21.88 (+10.95%)
Lowest
$20.00 (+1.42%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Kilichowski
Wells Fargo
Buy
Reiterated
$21.00
+6.5%
10/19/2026
Michael Goldsmith
UBS
Hold
Reiterated
$20.00
+1.4%
10/13/2026
Richard Hightower
Barclays
Hold
Maintained
$21.00
+6.5%
10/13/2026
Robert Stevenson
Janney Montgomery
Buy
Initiated
$23.00
+16.6%
09/09/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$23.00
+16.6%
09/01/2026
Vikram Malhotra
Mizuho Securities
Hold
Maintained
$21.00
+6.5%
08/31/2026
Farrell Granath
Bank of America Securities
Buy
Maintained
-
-
08/17/2026
Michael Lewis
Truist Financial
Buy
Maintained
$24.00
+21.7%
08/13/2026
Richard Anderson
Cantor Fitzgerald
Hold
Maintained
$22.00
+11.6%
08/10/2026
Dave Rodgers
Raymond James
Hold
Upgraded
$23.00
+16.6%
08/06/2026
Omotayo Okusanya
Deutsche Bank
Buy
Maintained
$25.00
+26.8%
07/22/2026
Wes Golladay
Robert W. Baird
Hold
Maintained
$23.00
+16.6%
07/22/2026
Aaron Hecht
Citizens JMP
Buy
Maintained
$25.00
+26.8%
07/22/2026
Nicholas Joseph
Citi
Hold
Downgraded
$19.00
-3.7%
06/23/2026
Seth Bergey
Citi
Hold
Downgraded
$19.00
-3.7%
06/23/2026
Nicholas Yulico
Scotiabank
Hold
Maintained
$19.00
-3.7%
06/18/2026
Unknown Analyst
Raymond James
Sell
Initiated
$18.73
-5%
06/16/2026
Juan C. Sanabria
BMO Capital
Hold
Maintained
$23.00
+16.6%
04/29/2026
Last report
Nov 3, 2026
Fiscal period
Q3 2026
$0.19 / $0.17
+15.39%beat
Revenue / Est. (USD)
249.56M / 236.37M
+5.58%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
191.26M
210.75M
223.66M
238.09M
Cost of goods sold
69.41M
80.01M
85.43M
194.72M
Cost of revenue
69.41M
80.01M
85.43M
194.72M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.56M
15.91M
14.86M
16.82M
Operating expense
62.44M
63.59M
67.99M
73.20M
Total operating expenses
131.85M
143.60M
153.42M
267.92M
Operating income
59.41M
67.15M
70.24M
-29.82M
Other non operating income
-
-3.66M
-55.00K
17.00K
EBT including unusual items
22.95M
27.64M
41.34M
-24.57M
EBT excluding unusual items
30.51M
34.55M
41.78M
-59.59M
Income tax expense
436.00K
491.00K
526.00K
678.00K
Effective tax rate
1.90%
1.78%
1.27%
-2.76%
Other operating expenses
1.37M
-3.72M
-
-
Net income
22.54M
27.22M
40.88M
-25.20M
Net profit margin
11.78%
12.92%
18.28%
-10.59%
Earnings per share
0.17
0.16
0.16
0.15
Interest and investment income
-
-
-
-
Interest expense
-28.90M
-28.94M
-28.41M
-29.78M
Net interest expenses
-28.90M
-28.94M
-28.41M
-29.78M
Depreciation and amortization charges
48.51M
51.40M
53.13M
56.38M
EBITDA
107.92M
113.68M
123.37M
26.55M
Gain or loss from assets sale
4.43M
9.06M
-
-37.72M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps